help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasmussen, S. K.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasmussen, S. K.
Right arrow Articles by Pedersen, O.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 4 1731-1734
Copyright © 2000 by The Endocrine Society

Comments

The -238 and -308 G->A Polymorphisms of the Tumor Necrosis Factor {alpha} Gene Promotor Are Not Associated with Features of the Insulin Resistance Syndrome or Altered Birth Weight in Danish Caucasians1

Søren K. Rasmussen, Søren A. Urhammer, Jan N. Jensen, Torben Hansen, Knut Borch-Johnsen and Oluf Pedersen

Steno Diabetes Center and Hagedorn Research Institute (S.K.R., S.A.U., J.N.J., T.H., O.P.), DK-2820, Gentofte, Denmark; and Center of Preventive Medicine (K.B.-J.), Glostrup University Hospital, DK-2600, Glostrup, Denmark

Address correspondence and requests for reprints to: Søren K. Rasmussen, M.Sc., Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.

Abstract

Recently, two G->A polymorphisms at positions -308 and -238, in the promoter of the tumor necrosis factor {alpha} (TNF-{alpha}) gene, have been identified. These variants have, in different ethnic groups, been linked to estimates of insulin resistance and obesity. The objective of the present study was to investigate whether these genetic variants of TNF-{alpha} were associated with features of the insulin resistance syndrome or alterations in birth weight in two Danish study populations comprising 380 unrelated young healthy subjects and 249 glucose-tolerant relatives of type 2 diabetic patients, respectively. All study participants underwent an iv glucose tolerance test with the addition of tolbutamide after 20 min. In addition, a number of biochemical and anthropometric measures were performed on each subject. The subjects were genotyped for the polymorphisms by applying PCR restriction fragment length polymorphism. Neither of the variants was related to altered insulin sensitivity index or other features of the insulin resistance syndrome (body mass index, waist to hip ratio, fat mass, fasting serum lipids or fasting serum insulin or C-peptide). Birth weight and the ponderal index were also not associated with the polymorphisms. In conclusion, although the study was carried out on sufficiently large study samples, the study does not support a major role of the -308 or -238 substitutions of the TNF-{alpha} gene in the pathogenesis of insulin resistance or altered birth weight among Danish Caucasian subjects.




This article has been cited by other articles:


Home page
 Hum ReprodHome page
Z. Z. Zhao, D. R. Nyholt, L. Le, S. Thomas, C. Engwerda, L. Randall, S. A. Treloar, and G. W. Montgomery
Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample
Hum. Reprod., September 1, 2007; 22(9): 2389 - 2397.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Asghar, S. Yoshida, S. Kennedy, K. Negoro, W. Zhuo, S. Hamana, S. Motoyama, S. Nakago, D. Barlow, and T. Maruo
The tumor necrosis factor-{alpha} promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population
Hum. Reprod., November 1, 2004; 19(11): 2509 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Jaquet, D. A. Tregouet, T. Godefroy, V. Nicaud, D. Chevenne, L. Tiret, P. Czernichow, and C. Levy-Marchal
Combined Effects of Genetic and Environmental Factors on Insulin Resistance Associated With Reduced Fetal Growth
Diabetes, December 1, 2002; 51(12): 3473 - 3478.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Straczkowski, I. Kowalska, A. Stepien, S. Dzienis-Straczkowska, M. Szelachowska, and I. Kinalska
Increased Plasma-Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic Subjects
Diabetes Care, October 1, 2002; 25(10): 1824 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. F. Escobar-Morreale, R. M. Calvo, J. Sancho, and J. L. San Millan
TNF-{alpha} and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3761 - 3767.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Rosmond, M. Chagnon, C. Bouchard, and P. Björntorp
G-308A Polymorphism of the Tumor Necrosis Factor {{alpha}} Gene Promoter and Salivary Cortisol Secretion
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2178 - 2180.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society